GYNE-LOTRIMIN 3

LOE ApproachingSM

clotrimazole

NDAVAGINALTABLET
Approved
Jul 1996
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
6

Clinical Trials (5)

NCT03599323N/ACompleted

Study on the Safety of the Approved Product Empedic L Cream During Its Routine Use (Active Ingredient is Clotrimazole 1%)

Started Jul 2018
1,033 enrolled
Vaginal Candida
NCT02180828Phase 4Completed

Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal Candidiasis

Started Jul 2014
240 enrolled
Candidiasis, Vulvovaginal
NCT01993823Phase 3Completed

Clinical Study to Assess the Efficacy and Safety of G238 Compared to Clotrimazole Otic Solution in the Treatment of Otomycosis

Started May 2013
190 enrolled
Otomycosis
NCT02184351Phase 3Completed

Clotrimazole vs. Mycelex® in Patients With Human Insufficiency Virus (HIV) Infection for the Treatment of Oropharyngeal Candidiasis

Started May 2001
187 enrolled
Candidiasis, Oral
NCT00002282N/ACompleted

A Comparison of the Safety and Effectiveness of Fluconazole or Clotrimazole in the Treatment of Fungal Infections of the Mouth and Throat in Patients With AIDS

Candidiasis, OralHIV Infections